Role of colchicine in the management of COVID-19 patients: A meta-analysis of cohort and randomized controlled trials
Background: Colchicine is well known drug for the treatment of acute gout. Recently, it has also been used in the management of COVID-19 patients. Aim: The aim of current study is to find out the role of colchicine in COVID-19 patients. Material & methods: The relevant studies were searched...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-07-01
|
| Series: | Clinical Epidemiology and Global Health |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2213398422001397 |
| _version_ | 1811308752321642496 |
|---|---|
| author | Avinash Kumar Singh Arya Vidyadhari Harmandeep Singh Kashif Haider Anoop Kumar Manju Sharma |
| author_facet | Avinash Kumar Singh Arya Vidyadhari Harmandeep Singh Kashif Haider Anoop Kumar Manju Sharma |
| author_sort | Avinash Kumar Singh |
| collection | DOAJ |
| description | Background: Colchicine is well known drug for the treatment of acute gout. Recently, it has also been used in the management of COVID-19 patients. Aim: The aim of current study is to find out the role of colchicine in COVID-19 patients. Material & methods: The relevant studies were searched in PubMed/Medline, Google scholar and clinical trail.gov.com till inception and sorted based on the inclusion and exclusion criteria. The quality assessment of studies were done using Newcastle Ottawa Quality Assessment Scale. The pooled estimate was calculated as odd ratio and pooled prevalence with 95% confidence interval. A random effect model was used and publication bias was assessed qualitatively by trim and fill method. Results: Out of 38 studies, a total of 6 studies were found relevant for the analysis containing 1146 patients (705 males and 441 females). The pooled odd ratio was found to be 0.35 [0.23, 0.53] which indicate significance reduction of mortality in colchicine group as compared to non-colchicine group. The pooled prevalence of the patients treated with colchicine were found to be significant [0.11(0.03, 0.24)]. The heterogeneity among studies was also found to be low (I2 = 11%). However, funnel plot has indicated the involvement of publication bias [Egger: bias = 10.168291 (95% CI = 5.042044 to 15.294537) P = 0.0053]. Conclusion: Colchicine might be helpful in reduction of mortality in the management of COVID-19 patients. However, further studies are required to confirm its exact role. |
| first_indexed | 2024-04-13T09:29:02Z |
| format | Article |
| id | doaj.art-6ea3632571214f5db64bb76e8b2a9a61 |
| institution | Directory Open Access Journal |
| issn | 2213-3984 |
| language | English |
| last_indexed | 2024-04-13T09:29:02Z |
| publishDate | 2022-07-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Clinical Epidemiology and Global Health |
| spelling | doaj.art-6ea3632571214f5db64bb76e8b2a9a612022-12-22T02:52:20ZengElsevierClinical Epidemiology and Global Health2213-39842022-07-0116101097Role of colchicine in the management of COVID-19 patients: A meta-analysis of cohort and randomized controlled trialsAvinash Kumar Singh0Arya Vidyadhari1Harmandeep Singh2Kashif Haider3Anoop Kumar4Manju Sharma5Department of Pharmaceutical Medicine (Division of Pharmacology) School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, 110062, IndiaDepartment of Pharmaceutics, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, 110062, IndiaDepartment of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysore, Karnataka, 570015, IndiaDepartment of Pharmaceutical Chemistry, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, 110062, IndiaDepartment of Pharmacology & Clinical Research, Delhi Pharmaceutical Sciences & Research University (DPSRU), New Delhi, 110017, India; Corresponding author. Department of Pharmacology & Clinical Research, Delhi Pharmaceutical Sciences & Research University (DPSRU), New Delhi, 110017, India.Department of Pharmacology, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, 110062, India; Corresponding author. Department of Pharmacology, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, 110062, India.Background: Colchicine is well known drug for the treatment of acute gout. Recently, it has also been used in the management of COVID-19 patients. Aim: The aim of current study is to find out the role of colchicine in COVID-19 patients. Material & methods: The relevant studies were searched in PubMed/Medline, Google scholar and clinical trail.gov.com till inception and sorted based on the inclusion and exclusion criteria. The quality assessment of studies were done using Newcastle Ottawa Quality Assessment Scale. The pooled estimate was calculated as odd ratio and pooled prevalence with 95% confidence interval. A random effect model was used and publication bias was assessed qualitatively by trim and fill method. Results: Out of 38 studies, a total of 6 studies were found relevant for the analysis containing 1146 patients (705 males and 441 females). The pooled odd ratio was found to be 0.35 [0.23, 0.53] which indicate significance reduction of mortality in colchicine group as compared to non-colchicine group. The pooled prevalence of the patients treated with colchicine were found to be significant [0.11(0.03, 0.24)]. The heterogeneity among studies was also found to be low (I2 = 11%). However, funnel plot has indicated the involvement of publication bias [Egger: bias = 10.168291 (95% CI = 5.042044 to 15.294537) P = 0.0053]. Conclusion: Colchicine might be helpful in reduction of mortality in the management of COVID-19 patients. However, further studies are required to confirm its exact role.http://www.sciencedirect.com/science/article/pii/S2213398422001397MortalityColchicineCOVID-19Meta-analysisCoronavirus |
| spellingShingle | Avinash Kumar Singh Arya Vidyadhari Harmandeep Singh Kashif Haider Anoop Kumar Manju Sharma Role of colchicine in the management of COVID-19 patients: A meta-analysis of cohort and randomized controlled trials Clinical Epidemiology and Global Health Mortality Colchicine COVID-19 Meta-analysis Coronavirus |
| title | Role of colchicine in the management of COVID-19 patients: A meta-analysis of cohort and randomized controlled trials |
| title_full | Role of colchicine in the management of COVID-19 patients: A meta-analysis of cohort and randomized controlled trials |
| title_fullStr | Role of colchicine in the management of COVID-19 patients: A meta-analysis of cohort and randomized controlled trials |
| title_full_unstemmed | Role of colchicine in the management of COVID-19 patients: A meta-analysis of cohort and randomized controlled trials |
| title_short | Role of colchicine in the management of COVID-19 patients: A meta-analysis of cohort and randomized controlled trials |
| title_sort | role of colchicine in the management of covid 19 patients a meta analysis of cohort and randomized controlled trials |
| topic | Mortality Colchicine COVID-19 Meta-analysis Coronavirus |
| url | http://www.sciencedirect.com/science/article/pii/S2213398422001397 |
| work_keys_str_mv | AT avinashkumarsingh roleofcolchicineinthemanagementofcovid19patientsametaanalysisofcohortandrandomizedcontrolledtrials AT aryavidyadhari roleofcolchicineinthemanagementofcovid19patientsametaanalysisofcohortandrandomizedcontrolledtrials AT harmandeepsingh roleofcolchicineinthemanagementofcovid19patientsametaanalysisofcohortandrandomizedcontrolledtrials AT kashifhaider roleofcolchicineinthemanagementofcovid19patientsametaanalysisofcohortandrandomizedcontrolledtrials AT anoopkumar roleofcolchicineinthemanagementofcovid19patientsametaanalysisofcohortandrandomizedcontrolledtrials AT manjusharma roleofcolchicineinthemanagementofcovid19patientsametaanalysisofcohortandrandomizedcontrolledtrials |